AbbVie, Johnson & Johnson, and Eli Lilly are noted as top holdings in specific healthcare ETFs.

The entities involved

• AbbVie →

  pharmaceutical company

  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
  • AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Sun 13:48
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
  • Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04
• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59

Related events

• AbbVie and Cisco are noted as large-cap holdings in the market.Sep 23
• Financial results and stock performance comparisons among AbbVie, Johnson & Johnson, Eli Lilly, and Merck.Aug 14
• AbbVie, Abbott Laboratories, and Johnson & Johnson were recommended as dividend stocks for retirees, operating in the healthcare sector.Jun 7
• Procter & Gamble, Johnson & Johnson, Coca-Cola, and Verizon are discussed as income-generating companies referenced in dividend investment strategies.Aug 25
• Reports on the top holdings of various healthcare and biotech ETFs, listing major pharmaceutical companies like Eli Lilly, Amgen, and Johnson & Johnson.Sep 10